Delan Khalid
ScholarGPS® ID: 23631061105988
Affiliation History
Field
Life Sciences
Discipline
Biology and Biological Sciences
Metrics Summary
Publication Count
8
Predicted Citations
3
Predicted h-index
1
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Leukemia, volume 38, issue 3, pages 521-529 (2024). |
Combining Menin and MEK Inhibition to Target Poor Prognostic KMT2A -Rearranged RAS Pathway-Mutant Acute Leukemia (journal article) Blood, volume 142, issue Supplement 1, pages 166-166 (2023). |
Blood, volume 142, issue Supplement 1, pages 4174-4174 (2023). |
Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors (journal article) Cancer Research, volume 83, issue 2, pages 285-300 (2023). |
P410: COMBINING MENIN AND MEK INHIBITION TO TREAT CHILDREN WITH POOR PROGNOSTIC KMT2A-R RAS-MUTANT ACUTE LEUKEMIA (journal article) HemaSphere, volume 7, issue S3, pages e0491723- (2023). |
Mechanisms of the CBFA2T3-GLIS2 Fusion in AML Maintenance (journal article) Blood, volume 140, issue Supplement 1, pages 5864-5865 (2022). |
Breaking the Pump: Targeting the Sodium-Potassium Pump As a Therapeutic Strategy in Acute Myeloid Leukemia (journal article) Blood, volume 140, issue Supplement 1, pages 4936-4937 (2022). |
Unleashing Cell-Intrinsic Inflammation As a Strategy to Kill AML Blasts (journal article) Blood, volume 138, issue Supplement 1, pages 3305-3305 (2021). |